https://clinicaltrials.gov/ct2/show/NCT03329508?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=08%2F15%2F2019&lupd_d=14&sort=nwst
STUDY TITLE:
A Phase 3 Study With P2B001 in Subjects With Early Parkinson’s
DESCRIPTION:
Condition: Parkinson Disease
Interventions: Drug: P2B001; Drug: Rasagiline; Drug: Pramipexole; Drug: Pramipexole ER
Sponsor: Pharma Two B Ltd.
Recruiting
CLINICALTRIALS.GOV IDENTIFIER:
NCT03329508
FIRST POSTED:
Mon, 06 Nov 2017 12:00:00 EST
LAST UPDATE POSTED:
08/29/19 10:25AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT03329508?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=08%2F15%2F2019&lupd_d=14&sort=nwst